Drug companies and patient groups: the influence of funding.
Patients should be able to rely on advocacy groups to push their interests, not those of pharmaceutical companies.
D000329:Advertising; D004345:Drug Industry / Q000191:economics*; D005378:Financial Support; D005602:France; D006801:Humans; D033181:Information Dissemination; D007880:Legislation, Drug; D008402:Mass Media; D010353:Patient Education as Topic